Bicara Therapeutics Appoints Jeltje Schulten as SVP of Clinical and Medical Affairs and Rita Dalal as Vice President of Clinical Development
Position
Vice President of Clinical Development
Company
Bicara Therapeutics
BostonBiotechnologyHealth CareTherapeuticsDescription
Bicara Therapeutics announced the appointments of Jeltje Schulten, M.D., MBA, as Senior Vice President of Clinical and Medical Affairs, and Rita Dalal, MBBS, MPH, as Vice President of Clinical Development.
Quick answer
Bicara Therapeutics Appoints Jeltje Schulten as SVP of Clinical and Medical Affairs and Rita Dalal as Vice President of Clinical Development (March 26, 2024). Bicara Therapeutics is based in Boston, Massachusetts, United States.
- Who is the new Vice President of Clinical Development at Bicara Therapeutics?
- Bicara Therapeutics named Rita Dalal Vice President of Clinical Development, announced March 26, 2024.
- What did Bicara Therapeutics announce on March 26, 2024?
- Bicara Therapeutics announced the appointments of Jeltje Schulten, M.D., MBA, as Senior Vice President of Clinical and Medical Affairs, and Rita Dalal, MBBS, MPH, as Vice President of Clinical Development.
- What does Bicara Therapeutics do?
- Bicara Therapeutics is a clinical-stage biotechnology company developing first-in-class biologics engineered to combine the precision of well validated, tumor-targeting antibodies with the power of tumor...
- Where is Bicara Therapeutics based?
- Bicara Therapeutics is based in Boston, Massachusetts, United States.
- Which similar companies made leadership changes around the same time?
- Rocket Pharmaceuticals (March 26, 2024), Poseida Therapeutics, Inc. (March 25, 2024), AVEO Pharmaceuticals (March 25, 2024) and IDRx (March 27, 2024) also announced leadership changes within 45 days of Bicara Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Rocket Pharmaceuticals, Inc. Appoints Aaron Ondrey as Chief Financial Officer (March 26, 2024)
- Poseida Therapeutics Appoints Syed Rizvi as Chief Medical Officer (March 25, 2024)
- AVEO Oncology Appoints Edgar E. Braendle as Chief Medical Officer (March 25, 2024)
- IDRx Appoints Dr. David P. Kerstein as Chief Medical Officer (March 27, 2024)
- John Cox Named President and CEO of Dyne Therapeutics (March 25, 2024)
- Transgene appoints Lucie Larguier as Chief Financial Officer and promotes Christelle Schwoerer to Chief Human Resources Officer (March 27, 2024)
Who to call at Bicara Therapeutics, and when
A new leader at Bicara Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Bicara Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Bicara Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Bicara Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Bicara Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Bicara Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.